Compare MRK & PG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRK | PG |
|---|---|---|
| Founded | 2000 | 1837 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.7B | 334.3B |
| IPO Year | 1994 | 2014 |
| Metric | MRK | PG |
|---|---|---|
| Price | $113.25 | $151.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 14 |
| Target Price | $125.59 | ★ $163.64 |
| AVG Volume (30 Days) | ★ 8.3M | 6.9M |
| Earning Date | 04-30-2026 | 04-24-2026 |
| Dividend Yield | ★ 3.06% | 2.89% |
| EPS Growth | 8.01 | ★ 8.14 |
| EPS | N/A | ★ 5.36 |
| Revenue | $65,011,000,000.00 | ★ $84,284,000,000.00 |
| Revenue This Year | $3.61 | $5.76 |
| Revenue Next Year | $5.41 | $2.57 |
| P/E Ratio | ★ N/A | $27.96 |
| Revenue Growth | ★ 1.31 | 0.29 |
| 52 Week Low | $76.66 | $137.62 |
| 52 Week High | $125.14 | $166.90 |
| Indicator | MRK | PG |
|---|---|---|
| Relative Strength Index (RSI) | 40.34 | 62.19 |
| Support Level | $106.12 | $150.97 |
| Resistance Level | $113.16 | $152.77 |
| Average True Range (ATR) | 2.99 | 2.83 |
| MACD | -0.71 | 0.84 |
| Stochastic Oscillator | 7.74 | 89.41 |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate annual global sales of more than $1 billion each, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.